MedPath

Objective Measurements of Lens Opacification After Intravitreal Injections

Withdrawn
Conditions
Lens Opacification
Intravitreal Injections (IVT)
Registration Number
NCT03964597
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

The main hypothesis is the opacification of the lens would be increase by the IVT.

The opacification of the lens can be objectived by :

* the objective scatter index (OSI) on the OQAS device

* the average lens density (ALD) on the IOLMaster device.

Eligible patients will be followed at least 12 months after in intravitreal injection and the opacification of their lens is regularly controlled with OSI and ALD.

The objective is to study the dynamics of lens opacification in IVT-treated eyes evaluated by OSI for at least 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Value of the OSI (Objective Scatter Index) in one year of follow-up after IVT12 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath